Diabetes Care Devices
Nemaura completes study of sugarBEAT glucose monitor
Nemaura Medical has completed a 100-patient study of the non-invasive and flexible continuous glucose monitor sugarBEAT. Carried out in the…
Abbott signs definitive agreement to acquire Bigfoot Biomedical
Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals…
DexCom launches connected CGM system with new AID feature in Germany
DexCom has initiated the Dexcom G6 Real-Time Continuous Glucose Monitoring System (rt-CGM), which can connect with the Omnipod 5 automated…
Nemaura receives SFDA approval for wearable glucose sensor
Nemaura Medical has received approval from the Saudi Food and Drug Authority (SFDA) for its non-invasive wearable glucose sensor, sugarBEAT.…
Nemaura Medical receives $6.5m in non-dilutive financing
UK-based medical technology company Nemaura Medical has obtained an additional $6.5m in non-dilutive funding from its existing lender. This funding…
Digital healthcare in the management of diabetes
Digital healthcare plays a crucial role in the management of diabetes by providing tools and resources to help people with…
How diabetes care is a model for precision medicine
The precision with which insulin can be used to manage diabetes is astounding and has a very real impact on…
FDA authorise Better Therapeutics’ digital therapeutic device
Better Therapeutics has received marketing authorisation from the US Food and Drug Administration (FDA) for its prescription-only digital behavioural therapeutic…
Dexcom G7 approved for use in Canada
Patients living with diabetes in Canada will soon be able to use Dexcom’s G7 device, following approval by Health Canada.…
Western Australia announces TeleTrial Programme for regional patients
The Government of Western Australia (WA) has announced the launch of the TeleTrial Programme by the WA Country Health Service.…